Abstract

Background: Injectable artesunate (inj AS) is a new anti-malarial treatment recently introduced in Sudan for the treatment of severe malaria . Inj AS has demonstrated its superiority over injectable quinine in African and Asian patients. This study aimed to evaluate the outcome of innovative teach-back tool kit session on the knowledge of inj AS among the postgraduate nursing students at the University of Khartoum, Sudan. 
 Methods: This interventional pre–posttest studyincluded30postgraduatenursing students selected though a full-coverage sampling method and meeting the selection criteria. Data were collected using standardized self-administered questionnaire after taking a written approval from the participants. The pretest included an initial assessment followed by implementation of interactive session about new anti-malaria treatment using an innovative teach-back toolkit, and the final assessment was conducted after two weeks (posttest). The collected data were then analyzed and interpreted using descriptive and inferential statistics based on the objective and hypothesis of the study. A two-tailed p-value at 0.05 was considered as the level of significance using SPSS version 20.
 Results:
 Majority of the participants were aged between 20 and 30years; of them, 26 (87%) were female and 4(13%) male, and all of them had >1year of experience. The findings of the study showed that half of the participants (15[50%]) had a good knowledge score, 12 (40%) had a poor knowledge, and 3(10%) had a very poor knowledge score in the pretest. However, the knowledge scores increased significantly to 86.7% posttest, which is very good. The overall mean of pretest knowledge scores regarding inj AS was7.4 with a statically significant difference (p=0.000). The mean score was increased to 12 with a statically significant difference posttest (p=0.000).
 Conclusion:
 There was a statistically significant improvement in the knowledge scores of the postgraduate nursing students about inj AS after the implementation of interactive teaching session using innovative teach-back tool kit.
 Keywords:inj artesunate, teach back-toolkit, nursing students, session

Highlights

  • Teach-back is a communication strategy in which the patients are asked to reiterate information provided to them using their own words, to confirm their understanding of the information.Teach-back isalso used as an educational approach to educate both the care givers and the patients about a new medication.The method is aproven teaching and learning strategy that improves the quality of care and ensures that healthcare professionals are educating patients and caregivers in an effective way to improve the efficacy with new medications [1]

  • H1: There will be a significant difference between pre- and posttest mean knowledge scores toward injectable artesunate using an innovative teach-back tool kit after implementation of the interactive teaching session

  • Data were collected, coded, entered, and analyzed using the statistical package for social sciences (SPSS) using mean, standard deviation, paired t-test, and P-value. In this interventional pre–posttest study,30 nurses were included and the collected data were tabulated, analyzed, and interpreted using description and inferential statistics based on the objective of the study

Read more

Summary

Introduction

The World Health Organization (WHO) guidelines have recommended inj artesunate (inj AS) as the preferred medicine for treating life-threatening conditions. Artesunate is a water-soluble hemisuccinate derivative of artemisinin indicated for the treatment of severe falciparum malaria and initiated treatment of uncomplicated falciparum malaria, when persistent vomiting precludes oral therapy It comes in the form of powder for injection in 20,60,120, and 160-mgvial with one 1-ml ampoule of 5% sodium bicarbonate and one 5-ml ampoule of 0.9%sodium chloride for slow IV injection (3–5 min) or slow IM injection. Some published studies showed higher rate of non-adherence of healthcare providers to the treatment guidelines and self-treatment In response to this situation, the malaria technical advisory committee (formed from national experts and partners) recommended the use of AL as a first-line and DHAP as a second-line treatment for malaria in Sudan. This study was done to evaluate the effect of an innovative teach-back tool kit session on the postgraduate nursing students’ knowledge about inj AS

Research hypotheses
Study population
Data collection methods
Structured interactive session
Results
11 Is IV artesunate safe in pregnancy and breast feeding?
Discussion
Hypothesis Testing
Limitations
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call